Factors predicting survival in peripheral T-cell lymphoma in the USA: A population-based analysis of 8802 patients in the modern era

British Journal of Haematology

Volumn 168, Issue 5, 2015, Pages 708-718

  Petrich, Adam M ^a,b   Helenowski, Irene B ^b   Bryan, Locke J ^a,b   Rozell, Shaina A ^a,b   Galamaga, Robert ^c   Nabhan, Chadi ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^d SECTION OF HEMATOLOGY ONCOLOGY   (United States)

Author keywords

Histopathology; Prognostic factors; Radiotherapy; T cell lymphoma

Indexed keywords

ADULT; AGE; AGED; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; BLACK PERSON; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; ENTEROPATHY; ENTEROPATHY TYPE INTESTINAL T CELL LYMPHOMA; FEMALE; FOLLOW UP; HAZARD RATIO; HEPATOSPLENIC DELTA T CELL LYMPHOMA; HEPATOSPLENIC GAMMA T CELL LYMPHOMA; HEPATOSPLENOMEGALY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODERN TIMES; MULTIVARIATE ANALYSIS; NATURAL KILLER T CELL; NK T CELL LYMPHOMA; OVERALL SURVIVAL; PERIPHERAL T CELL LYMPHOMA; POPULATION BASED CASE CONTROL STUDY; PREDICTION; PROPORTIONAL HAZARDS MODEL; SUBCUTANEOUS T CELL LYMPHOMA; SURVIVAL RATE; T CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA; T CELL PROLYMPHOCYTIC LEUKAEMIA; TREND STUDY; UNITED STATES; UNIVARIATE ANALYSIS; VERY ELDERLY; YOUNG ADULT; BIOLOGICAL MODEL; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; INCIDENCE; LYMPHOMA, T-CELL, PERIPHERAL; MORTALITY; NATURAL KILLER CELL; PATHOLOGY; RISK FACTOR; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, PERIPHERAL; MIDDLE AGED; MODELS, BIOLOGICAL; RISK FACTORS; SURVIVAL RATE; T-LYMPHOCYTES; UNITED STATES;

EID: 84922779526     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13202     Document Type: Article

References (42)

1. Abouyabis, A.N., Shenoy, P.J., Lechowicz, M.J. & Flowers, C.R. (2008) Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leukaemia & Lymphoma, 49, 2099-2107.
2. d'Amore, F., Relander, T., Lauritzsen, G.F., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Osterborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Ostenstad, B., Fagerli, U.M., Gadeberg, O.V., Sundstrom, C., Delabie, J., Ralfkiaer, E., Vornanen, M. & Toldbod, H.E. (2012) Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. Journal of Clinical Oncology, 30, 3093-3099.
3. Armitage, J. (2012) The aggressive peripheral T-cell lymphomas: 2012 Update on diagnosis risk stratification, and management. American Journal of Hematology, 87, 512-519.
4. Chan, J.K. (2001) The new World Health Organization classification of lymphomas: the past, the present and the future. Hematological Oncology, 19, 129-150.
5. Coiffier, B., Pro, B., Prince, H.M., Foss, F., Sokol, L., Greenwood, M., Caballero, D., Borchmann, P., Morschhauser, F., Wilhelm, M., Pinter-Brown, L., Padmanabhan, S., Shustov, A., Nichols, J., Carroll, S., Balser, J., Balser, B. & Horwitz, S. (2012) Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy. Journal of Clinical Oncology, 30, 631-636.
6. Dignam, J.J., Colangelo, L., Tian, W., Jones, J., Smith, R., Wickerham, D.L. & Wolmark, N. (1999) Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. Journal of the National Cancer Institute, 91, 1933-1940.
7. Ederer, F. & Heise, H. (1959) Instructions to Ibm 650 Programmers in Processing Survival Computations, Technical. End Results Evaluation Section. National Cancer Institute, Bethesda, MD.
8. Fernandes, A.T., Svoboda, J., Nasta, S.D., Wilson, L.D. & Plastaras, J.P. (2013) Radiation therapy in peripheral T-cell lymphoma of the head and neck. Blood (ASH Annual Meeting Abstracts), 122, 1795.
9. Foss, F., Zinzani, P.L., Vose, J.M., Gascoyne, R.D., Rosen, S.T. & Tobinai, K. (2011) Peripheral T-cell lymphoma. Blood, 117, 6756-6767.
10. Gallamini, A., Stelitano, C., Calvi, R., Bellei, M., Mattei, D., Vitolo, U., Morabito, F., Martelli, M., Brusamolino, E., Iannitto, E., Zaja, F., Cortelazzo, S., Rigacci, L., Devizzi, L., Todeschini, G., Santini, G., Brugiatelli, M., Federico, M. & Intergruppo Italiano Linfomi. (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood, 103, 2474-2479.
11. George, L.C., Rowe, M. & Fox, C.P. (2012) Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved. Current Hematologic Malignancy Reports, 7, 276-284.
12. Gisselbrecht, C., Gaulard, P., Lepage, E., Coiffier, B., Briere, J., Haioun, C., Cazals-Hatem, D., Bosly, A., Xerri, L., Tilly, H., Berger, F., Bouhabdallah, R. & Diebold, J. (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood, 92, 76-82.
13. Gutierrez-Garcia, G., Garcia-Herrera, A., Cardesa, T., Martinez, A., Villamor, N., Ghita, G., Martinez-Trillos, A., Colomo, L., Setoain, X., Rodriguez, S., Gine, E., Campo, E. & Lopez-Guillermo, A. (2011) Comparison of four prognostic scores in peripheral T-cell lymphoma. Annals of Oncology, 22, 397-404.
14. Hasenclever, D. & Diehl, V. (1998) A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. New England Journal of Medicine, 339, 1506-1514.
15. Hoffman, R.M., Gilliland, F.D., Eley, J.W., Harlan, L.C., Stephenson, R.A., Stanford, J.L., Albertson, P.C., Hamilton, A.S., Hunt, W.C. & Potosky, A.L. (2001) Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. Journal of the National Cancer Institute, 93, 388-395.
16. Hoster, E., Dreyling, M., Klapper, W., Gisselbrecht, C., Van Hoof, A., Kluin-Nelemans, H.C., Pfreundschuh, M., Reiser, M., Metzner, B., Einsele, H., Peter, N., Jung, W., Wormann, B., Ludwig, W.D., Duhrsen, U., Eimermacher, H., Wandt, H., Hasford, J., Hiddemann, W., Unterhalt, M., German Low Grade Lymphoma Study, G. & European Mantle Cell Lymphoma, N. (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood, 111, 558-565.
17. Huang, L., Zalkikar, J. & Tiwari, R.C. (2011) A likelihood ratio test based method for signal detection with application to FDA's drug data. Journal of the American Statistical Association, 106, 1230-1241.
18. Iqbal, J., Weisenburger, D.D., Greiner, T.C., Vose, J.M., McKeithan, T., Kucuk, C., Geng, H., Deffenbacher, K., Smith, L., Dybkaer, K., Nakamura, S., Seto, M., Delabie, J., Berger, F., Loong, F., Au, W.Y., Ko, Y.H., Sng, I., Armitage, J.O., Chan, W.C. & International Peripheral T-Cell Lymphoma Project. (2010) Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood, 115, 1026-1036.
19. Jaffe, E.S. (2006) Pathobiology of peripheral T-cell lymphomas. Hematology American Society of Hematology Education Program, 2006, 317-322.
20. Jamal, S., Picker, L.J., Aquino, D.B., McKenna, R.W., Dawson, D.B. & Kroft, S.H. (2001) Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach. American Journal of Clinical Pathology, 116, 512-526.
21. Kutok, J.L. & Aster, J.C. (2002) Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma. Journal of Clinical Oncology, 20, 3691-3702.
22. Lee, H.K., Wilder, R.B., Jones, D., Ha, C.S., Pro, B., Rodriguez, M.A., Romaguera, J.E., Cabanillas, F., Rodriguez, J. & Cox, J.D. (2002) Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas. Leukaemia & Lymphoma, 43, 1769-1775.
23. Mahieux, R. & Gessain, A. (2003) HTLV-1 and associated adult T-cell leukemia/lymphoma. Reviews in Clinical and Experimental Hematology, 7, 336-361.
24. Morgensztern, D., Walker, G., Koniaris, L.G. & Lossos, I.S. (2011) Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysis. Leukemia & Lymphoma, 52, 194-204.
25. Morton, L., Wang, S.S., Devesa, S.S., Hartge, P., Weisenburger, D.D. & Linet, M.S. (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 107, 265-276.
26. Newman, L.A., Griffith, K.A., Jatoi, I., Simon, M.S., Crowe, J.P. & Colditz, G.A. (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. Journal of Clinical Oncology, 24, 1342-1349.
27. O'Connor, O.A., Pro, B., Pinter-Brown, L., Bartlett, N., Popplewell, L., Coiffier, B., Lechowicz, M.J., Savage, K.J., Shustov, A.R., Gisselbrecht, C., Jacobsen, E., Zinzani, P.L., Furman, R., Goy, A., Haioun, C., Crump, M., Zain, J.M., Hsi, E., Boyd, A. & Horwitz, S. (2011) Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. Journal of Clinical Oncology, 29, 1182-1189.
28. O'Connor, O.A., Masszi, T., Savage, K.J., Pinter-Brown, L.C., Foss, F.M., Popplewell, L., Cashen, A.F., Doorduijn, J., Chawla, S., Knoblauch, P., Zinzani, P.L., Brown, P., Hess, G., Van Hoof, A., Horwitz, S.M. & Shustov, A.R. (2013) Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): results from the BELIEF trial. Journal of Clinical Oncology, 31 (suppl; abstr 8507).
29. O'Leary, H. & Savage, K.J. (2009) The spectrum of peripheral T-cell lymphomas. Current Opinion in Hematology, 16, 292-298.
30. Olszewski, A.J. & Desai, A. (2014) Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. International Journal of Radiation Oncology Biology Physics, 88, 642-649.
31. Park, H.S., Gross, C.P., Makarov, D.V. & Yu, J.B. (2012) Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. International Journal of Radiation Oncology Biology Physics, 83, 1365-1373.
32. Petrich, A.M., Helenowski, I., Galamaga, R.W. & Nabhan, C. (2012) Trends in incidence and outcome in T-cell lymphoma since 1992: A SEER database analysis. Blood (ASH Annual Meeting Abstracts), 120, 4264.
33. Pro, B., Advani, R., Brice, P., Bartlett, N.L., Rosenblatt, J.D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M., Connors, J.M., Yang, Y., Sievers, E.L., Kennedy, D.A. & Shustov, A. (2012) Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study. Journal of Clinical Oncology, 30, 2190-2196.
34. Savage, K.J., Harris, N.L., Vose, J.M., Ullrich, F., Jaffe, E.S., Connors, J.M., Rimsza, L., Pileri, S.A., Chhanabhai, M., Gascoyne, R.D., Armitage, J.O. & Weisenburger, D.D. (2008) ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood, 111, 5496-5504.
35. Schmitz, N., Trumper, L., Ziepert, M., Nickelsen, M., Ho, A.D., Metzner, B., Peter, N., Loeffler, M., Rosenwald, A. & Pfreundschuh, M. (2010) Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood, 116, 3418-3425.
36. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. International Agency for Research on Cancer Press, Lyon, France.
37. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. New England Journal of Medicine, 329, 987-994.
38. Tse, E. & Kwong, Y.L. (2013) How I treat NK/T-cell lymphomas. Blood, 121, 4997-5005.
39. Vose, J. (2005) International Peripheral T-cell Lymphoma (PTCL) Clinical and Pathology Review Project: poor outcome by prognostic indices and lack of efficacy with anthracyclines. Blood (ASH Annual Meeting Abstracts), 106, 811a.
40. Vose, J., Armitage, J., Weisenburger, D. & International T-Cell Lymphoma Project. (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. Journal of Clinical Oncology, 26, 4124-4130.
41. Went, P., Agostinelli, C., Gallamini, A., Piccaluga, P.P., Ascani, S., Sabattini, E., Bacci, F., Falini, B., Motta, T., Paulli, M., Artusi, T., Piccioli, M., Zinzani, P.L. & Pileri, S.A. (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. Journal of Clinical Oncology, 24, 2472-2479.
42. Zhang, X.M., Li, Y.X., Wang, W.H., Jin, J., Wang, S.L., Liu, Y.P., Song, Y.W., Fang, H., Ren, H., Zhou, L.Q., Liu, X.F. & Yu, Z.H. (2013) Survival advantage with the addition of radiation therapy to chemotherapy in early stage peripheral T-cell lymphoma, not otherwise specified. International Journal of Radiation Oncology Biology Physics, 85, 1051-1056.